[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339390-105":59,"doc-detail-339390-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-discovery-of-somatic-mutations-from-rna-sequencing-data","Pan-cancer discovery of somatic mutations from RNA sequencing data","","Identification of somatic mutations (SMs) is essential for characterizing cancer genomes, yet DNA sequencing is not the only route. RNA sequencing (RNA-seq) enables an alternative strategy because the transcriptome reflects a transcribed genome. A machine learning–based pipeline, IMAPR, is developed to discover RNA-based SMs (RNA-SMs) from cancer RNA-seq data. Applied to 8,048 TCGA tumors, IMAPR uncovers over 105,000 novel SMs not found in prior DNA-seq analyses, and an updated pan-cancer mutation landscape is released as OncoDB.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-discovery-of-somatic-mutations-from-rna-sequencing-data/339390/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-discovery-of-somatic-mutations-from-rna-sequencing-data/339390.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is RNA-seq useful for discovering somatic mutations in cancer?","Question",{"text":112,"@type":113},"RNA-seq provides information from the transcribed genome, enabling detection of tumor mutations in exonic regions, including low-frequency events that may be difficult to observe with DNA-seq.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is IMAPR and what does it do?",{"text":117,"@type":113},"IMAPR is a machine learning–based bioinformatics pipeline designed to discover somatic mutations from RNA-seq data, using multiple mutation filters tailored to RNA-seq characteristics.",{"name":119,"@type":110,"acceptedAnswer":120},"How were the RNA-SM findings used to build a broader cancer resource?",{"text":121,"@type":113},"RNA-SMs identified across TCGA tumors were combined with DNA-seq-based somatic mutations to depict an updated mutational landscape across 32 cancer types, which is provided as the OncoDB online SM atlas.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339390,1790195299,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","communications biology Article  \n[https://doi.org/10.1038/s42003-024-06326-y](https://doi.org/10.1038/s42003-024-06326-y)  \nPan-cancer discovery of somatic mutations from RNA sequencing data  \n Check for updates  \n\n| Gongyu Tang1,2, Xinyi Liu1, Minsu Cho1, Yuanxiang Li 1, Dan-Ho Tran1 & Xiaowei Wang 1,3  |  |\n| --- | --- |\n| Identiﬁcation of somatic mutations (SMs) is essential for characterizing cancer genomes. While DNAseq is the prevalent method for identifying SMs, RNA-seq provides an alternative strategy to discover tumor mutations in the transcribed genome. Here, we have developed a machine learning based pipeline to discover SMs based on RNA-seq data (designated as RNA-SMs) . Subsequently, we have conducted a pan-cancer analysis to systematically identify RNA-SMs from over 8,000 tumors in The Cancer Genome Atlas (TCGA) . In this way, we have identiﬁed over 105,000 novel SMs that had not been reported in previous TCGA studies. These novel SMs have signiﬁcant clinical implications in designing targeted therapy for improved patient outcomes. Further, we have combined the SMsidentiﬁed by both RNA-seq and DNA-seq analyses to depict an updated mutational landscape across 32 cancer types. This new online SM atlas, OncoDB ([https://oncodb.org](https://oncodb.org)), offers a more complete view of gene mutations that underline the development and progression of various cancers. |  |\n| The detection of somatic mutations (SMs) is critical in characterizing the cancer genome1. Historically, SMs were identiﬁed using Sanger sequencing or RT-PCR techniques2. These low throughput methods were limited to designated sequences, resulting in high experimental costs when examining multiple genomic regions. With the development of next-generation sequencing (NGS) technologies, the detection of SMs in the whole exomes or genomes has become much more efﬁcient and cost-friendly using DNA sequencing (DNA-seq) methods3,4. Currently, researchers commonly employ DNA-seq to identify SMs to investigate the underlying mechanisms of cancer initiation and progression.\u003Cbr>RNA sequencing (RNA-seq) is another type of NGS approach that is commonly employed for gene expression proﬁling analysis5,6. Since the transcriptome represents a cell’s transcribed genome, it is feasible to detect SMs based on RNA-seq data (designated as RNA-SMs) in cancer. In particular, RNA-seq analysis can identify low-frequency mutations in exonic regions that may not be observable in DNA-seq data7. To this end, multiple bioinformatics strategies have been developed for detecting SMs based on RNA-seq data. For instance, Shenget al. identiﬁedSMsusinga bias-reduced generalized linear model, which was trained on features extracted from RNA-seq data8; Yizhak et al. designed an alignment strategy to minimize read errors in RNA-seq data9; Muyas et al. developed a machine learning model to distinguish somatic variants from germline variants presented in RNA-seq data10.\u003Cbr>While these bioinformatics methods have enabled SM detection using RNA-seq data, they had their limitations. Ofnote, existing methods did not comprehensively consider unique characteristics relevant to RNA-seq data, | such as those related to exon splicing, adapter clipping, or RNA editing. Furthermore, most existing methods rely on a single sequence aligner in conjunction with a single variant caller; this strategy could introduce bias that is speciﬁcally associated with individual aligners or variant callers, potentially resulting in a relatively high rate of false discoveries. In addition, most existing methods were tailored for the analysis of speciﬁcdatasets and may not be broadly applied to pan-cancer discovery of RNA-SMs. Thus, there is a strong demand to develop a robust RNA-SM discovery pipeline that can be utilized in diverse types of cancer. To this end, we developed a bioinformatics pipeline, the Integrated Mutation Analysis Pipeline for RNA-seq data (IMAPR), for RNA-SM discovery. Importantly, we applied IMAPRt","cbCaitWWaCtX425P","https://ap.wps.com/l/cbCaitWWaCtX425P","pdf",2201995,12,"English","# Introduction\n## Limitations of existing RNA-SM detection methods\n## IMAPR pipeline and pan-cancer application\n# Results\n## Developing an RNA-SM detection pipeline","[{\"question\":\"Why is RNA-seq useful for discovering somatic mutations in cancer?\",\"answer\":\"RNA-seq provides information from the transcribed genome, enabling detection of tumor mutations in exonic regions, including low-frequency events that may be difficult to observe with DNA-seq.\"},{\"question\":\"What is IMAPR and what does it do?\",\"answer\":\"IMAPR is a machine learning–based bioinformatics pipeline designed to discover somatic mutations from RNA-seq data, using multiple mutation filters tailored to RNA-seq characteristics.\"},{\"question\":\"How were the RNA-SM findings used to build a broader cancer resource?\",\"answer\":\"RNA-SMs identified across TCGA tumors were combined with DNA-seq-based somatic mutations to depict an updated mutational landscape across 32 cancer types, which is provided as the OncoDB online SM atlas.\"}]","Pan-cancer discovery of somatic mutations from RNA sequencing data | PDF",1790029991,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d83fb2fa5e4b01e6523773c1d6bcfc9.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ed328f49903308b46ac994ca9e69272.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14e543ae8dda04c6baacf538d3227b57.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/adc08067b91aa68bb889003e1ae2c917.webp",980,1301]